Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Xerapeutics Holding AB
AB
Active
Org 5595052407
Economic activity was not specified by tax authority
·
NACE 0000
Est. 2024 · 1 year old
0 employees
Monitor
Share
Sweden
/
Companies
/
Economic activity was not specified by tax authority
/
Xerapeutics Holding AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
EBITDA
SEK millions
0M
0M
0M
-1M
-1M
2025: 0M
0M
2025
Income statement
SEK thousands
Item
2025
Revenue
0
Staff expenses
—
EBITDA
−86
Depreciation & amort.
—
EBIT
−86
Net financials
—
Profit before tax
−86
Tax
—
Net profit
−86
Balance sheet
SEK thousands
Item
2025
Total assets
10 007
Equity
164
Long-term debt
9 800
Short-term debt
43
Total debt
9 843
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2025
2025
Equity ratio
1,6 %
This company
38,2 %
Market median
This company
Market median
96% below market
2025
2025
Return on equity
−52,4 %
This company
18,4 %
Market median
This company
Market median
385% below market
2025
2025
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2025
2025
Asset turnover
0,00×
This company
1,12×
Market median
This company
Market median
100% below market
2025
2025
Debt / equity
60,00×
This company
0,62×
Market median
This company
Market median
>999% above market
2025
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-11-15 – 2025-12-31
View
PDF
More on Xerapeutics Holding AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
